Search Results - "Löser, Heike"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma by Damanakis, Alexander I., Wahler, Isabell, Fuchs, Hans, Löser, Heike, Schröder, Wolfgang, Zander, Thomas, Chon, Seung-Hun, Bruns, Christiane, Quaas, Alexander, Gebauer, Florian

    Published in Scientific reports (01-12-2022)
    “…Today, individual prognosis in patients with adenocarcinoma of the esophagus (EAC) is based on post-surgical TNM staging and valid biomarkers are still not…”
    Get full text
    Journal Article
  6. 6

    Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma by Raters, Verena Maria, Gebauer, Florian, Löser, Heike, Schröder, Wolfgang, Schlösser, Hans Anton, Fuchs, Hans, Bruns, Christiane, Quaas, Alexander, Zander, Thomas

    Published in Frontiers in oncology (17-11-2023)
    “…Background Staging, especially clinical lymph node staging in esophageal adenocarcinoma has only moderate sensitivity and specificity. Therefore, we evaluated…”
    Get full text
    Journal Article
  7. 7
  8. 8

    First reported case of a collision tumor composed of pancreatic adenocarcinoma and retroperitoneal liposarcoma: a case report by Buchner, Denise, Hieggelke, Lena, Löser, Heike, Bruns, Christiane Josephine, Quaas, Alexander, Ghadimi, Markus Philipp Hussein

    Published in BMC cancer (12-12-2018)
    “…Collision tumors are rare cases with two different tumor entities growing synchronously. While adenocarcinoma of the pancreas is the most common pancreatic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma by Fries, Jochen W. U., Störkel, Stefan, Gödde, Daniel, Kallinowski, Joachim P., Löser, Heike, Schlosser, Monika, Puetz, Katharina, von Brandenstein, Melanie, Büttner, Reinhard

    Published in Disease markers (01-01-2015)
    “…Vimentin is currently used to differentiate between malignant renal carcinomas and benign oncocytomas. Recent reports showing Vimentin positive oncocytomas…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Expression of Immune Checkpoint Regulators IDO, VISTA, LAG3, and TIM3 in Resected Pancreatic Ductal Adenocarcinoma by Popp, Felix C, Capino, Ingracia, Bartels, Joana, Damanakis, Alexander, Li, Jiahui, Datta, Rabi R, Löser, Heike, Zhao, Yue, Quaas, Alexander, Lohneis, Philipp, Bruns, Christiane J, On Behalf Of The Pancalyze Study Group

    Published in Cancers (29-05-2021)
    “…Pancreatic cancer features elaborate mechanisms of immune evasion. The potential of new immune molecules was explored to restore the antitumor immune response…”
    Get full text
    Journal Article
  19. 19

    PS02.197: UPREGULATION OF IMP3 HAS A NEGATIVE PROGNOSTIC IMPACT IN EARLY INVASIVE ESOPHAGEAL ADENOCARCINOMA by Plum, Patrick, Ulase, Dita, Chon, Seung-Hun, Berlth, Felix, Zander, Thomas, Alakus, Hakan, Bollschweiler, Elfriede, Hölscher, Arnulf, Bruns, Christiane, Quaas, Alexander, Löser, Heike

    Published in Diseases of the esophagus (01-09-2018)
    “…Abstract Background Despite improvements in perioperative treatments, the overall survival of patients with esophageal adenocarcinoma (EAC) remains low. In…”
    Get full text
    Journal Article
  20. 20